| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.65 | 1e-08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.53 | 1e-07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |